Cowealth Medical China Co.,Ltd. (SHA:603122)
China · Delayed Price · Currency is CNY 16.99
+0.21 (1.25%)
Feb 25, 2026, 4:00 PM EST
Cowealth Medical China Market Cap
Cowealth Medical China has a market cap or net worth of 6.76 billion as of February 26, 2026. Its market cap has increased by 149.12% in one year.
Market Cap
6.76B
Enterprise Value
6.60B
Revenue
777.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.99
Market Cap Chart
Since February 16, 2022, Cowealth Medical China's market cap has increased from 2.40B to 6.76B, an increase of 181.76%. That is a compound annual growth rate of 29.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 6.76B | -30.37% |
| Dec 31, 2025 | 9.71B | 248.07% |
| Dec 31, 2024 | 2.79B | -12.92% |
| Dec 29, 2023 | 3.20B | -28.13% |
| Dec 30, 2022 | 4.46B | 85.74% |
| Feb 16, 2022 | 2.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Runda Medical Technology | 9.62B |
| Amoy Diagnostics | 8.02B |
| Beijing Strong Biotechnologies,Inc. | 7.58B |
| Maccura Biotechnology Co.Ltd | 7.07B |
| SMO ClinPlus CO.,LTD. | 5.42B |
| Thalys Medical Technology Group | 4.50B |
| Shanghai Labway Clinical Laboratory | 4.46B |
| Berry Genomics Co.,Ltd | 4.35B |